Cost-effectiveness of vaccination of immunocompetent older adults against herpes zoster in the Netherlands: a comparison between the adjuvanted subunit and live-attenuated vaccines

Cost-effectiveness of vaccination of immunocompetent older adults against herpes zoster in the Netherlands: a comparison between the adjuvanted subunit and live-attenuated vaccines

Abstract Background The newly registered adjuvanted herpes zoster subunit vaccine (HZ/su) has a higher efficacy than the available live-attenuated vaccine (ZVL). National decision-makers soon need to decide whether to introduce HZ/su or to prefer HZ/su above ZVL. Methods Using a Markov model with a...

Full description

Bibliographic Details
Main Authors: Pieter T. de Boer, Alies van Lier, Hester de Melker, Albert J. M. van Wijck, Jan C. Wilschut, Albert Jan van Hoek, Maarten J. Postma
Format: Article
Language:English
Published: BMC 2018-12-01
Series:BMC Medicine
Subjects:
Herpes zoster
Cost-effectiveness
Vaccination
Post-herpetic neuralgia
Subunit vaccine
Live-attenuated vaccine
Online Access:http://link.springer.com/article/10.1186/s12916-018-1213-5

Internet

http://link.springer.com/article/10.1186/s12916-018-1213-5

Similar Items